10x Genomics, Inc. (TXG) short interest & options flow
NASDAQ10x Genomics hits its November 4 earnings date carrying three distinct tensions at once: a short position that has been cut nearly in half since late September, an analyst consensus that still lags the price, and an ORTEX forecast that puts a 60% chance of a Russell index reshuffle on December 11. The most striking feature of the positioning picture is how fast short sellers have…
TXG short interest falls 27.5% over one week to 10.4% of free float, down from highs near 15.9% in early October.
- Market cap
- $8.51B
- Next earnings
- 4 Nov 2026
Key data as of 4 Nov 2026
Latest signals on TXG
- Short Interest
TXG short interest falls 27.5% over one week to 10.4% of free float, down from highs near 15.9% in early October.
2 Short Interest updates in 30 days
TXG news and analysis
RSSNo long-form analysis yet for TXG. Pulse alerts and the live data picture are available on ORTEX.
Open TXG on ORTEX →Want the live picture for TXG?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TXG — free to start on ORTEX.
Sign up for free →Open TXG on ORTEX